Gujarat Inject Kerala Ltd (524238)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Gujarat Inject's revenue was ₹12.5 Cr (+414.6% year on year, -59.4% on the previous quarter), and net profit ₹1.3 Cr; the operating margin was 13.6%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹12.5 | +414.6% | -59.4% |
| Operating profit | ₹1.7 | — | -25.7% |
| Net profit | ₹1.3 | — | -23.7% |
| EPS (₹) | adj. 0.09 | — | -21.8% |
| Operating margin | 13.6% | — | — |
EPS restated for the ₹10 to ₹1 split of Jul 2026: Q1 FY27 ₹0.86 to ₹0.09.
📢 Recent Corporate Announcements
Gujarat Inject Kerala Ltd has secured a purchase order valued at approximately ₹6.25 crore from Deon Energy Limited. The contract entails the supply and arrangement of 8,065 solar modules of 620 Wp. The order represents roughly 13.6% of the company's TTM revenue of ₹46 crore and is slated for completion within October 2026. The contract does not involve related party transactions.
- Received purchase order valued at around ₹6.25 crore from Deon Energy Limited
- Scope covers supply and arrangement of 8,065 solar modules of 620 Wp
- Scheduled for completion by October 2026
- Order value represents ~13.6% of TTM revenue (₹46 crore)
Gujarat Inject Kerala Ltd has secured a domestic purchase order valued at around ₹6.25 Crore (exclusive of GST) from Deon Energy Limited. The contract entails supplying 8,065 units of 620 Wp solar panels, to be executed within October 2026. This order represents approximately 13.6% of the company's TTM revenue of ₹46 Crore and roughly 20.8% of its current market cap of ₹30 Crore. The order does not involve any related-party transactions.
- Purchase order value of around ₹6.25 Crores (exclusive of GST)
- Contract scope covers 8,065 units of 620 Wp solar panels
- Awarded by domestic entity Deon Energy Limited
- Scheduled for execution within October 2026
- Non-related party transaction with no promoter interest
Gujarat Inject Kerala Ltd announced a major business pivot toward renewable energy, securing a ₹4.86 crore order from Zentaraa Infra Projects for 3,600 Solar PV modules to be executed in October 2026. The company capitalized ₹2,076.45 lacs (₹20.76 crore) as Capital Work in Progress (CWIP) toward a solar power project following an agreement with Soleos Energy. For FY26, total revenue reached ₹3,632.04 lacs (₹36.32 crore) and PAT rose to ₹181.41 lacs (₹1.81 crore), driven largely by its asset-light trading operations. No operational revenue was recorded from the solar generation project in FY26 as consideration discharge remains pending.
- Secured domestic purchase order worth ₹4.86 crore (exclusive of GST) for 3,600 Solar PV Modules from Zentaraa Infra Projects.
- Recognized ₹2,076.45 lacs as Capital Work in Progress (CWIP) toward Solar Power Generation Project.
- FY26 total revenue almost doubled to ₹3,632.04 lacs compared to ₹1,904.58 lacs in FY25.
- FY26 PAT grew to ₹181.41 lacs from ₹101.72 lacs in the previous fiscal year.
- Order execution scheduled for October 2026, while solar project capitalization was flagged as a Key Audit Matter by auditors.
Gujarat Inject Kerala Ltd has secured a domestic purchase order valued at approximately ₹4.86 crore (exclusive of GST) from Zentaraa Infra Projects Private Limited. The order entails supplying 3,600 solar PV modules across required sites and is scheduled for execution within October 2026. The contract represents approximately 10.6% of the company's TTM revenue of ₹46 crore and around 16.2% of its ₹30 crore market cap. Notably, the company, traditionally classified under pharmaceuticals, continues to register revenue from solar supply contracts.
- Order value is approximately ₹4.86 crore (exclusive of GST)
- Contract involves the supply of 3,600 units of Solar PV Modules
- Scheduled for rapid execution within October 2026
- Customer is domestic entity Zentaraa Infra Projects Private Limited, with no promoter or related-party interest
Gujarat Inject (Kerala) Limited has entered into a strategic business partnership with UK-based Storenergy Limited to explore Renewable Energy Storage Technology (REST) opportunities in India. The agreement establishes a framework to identify, evaluate, and develop potential storage projects. Commercial terms and financial arrangements for individual projects remain unfinalized and will be decided at a later stage. The company reported a net profit of Rs 1.25 cr on revenue of Rs 12.45 cr in the June 2026 quarter.
- Entered strategic partnership with UK-based Storenergy Limited for Renewable Energy Storage Technology (REST) in India.
- Commercial terms for individual projects are not yet finalized and will be agreed upon at a later stage.
- Transaction confirmed to be a non-related party transaction.
- Company posted revenue of Rs 12.45 cr and PAT of Rs 1.25 cr in the Jun 2026 quarter.
Gujarat Inject Kerala Ltd has entered into a Strategic Business Partnership and Framework Agreement with UK-based Storenergy Limited to evaluate, develop, and pursue Thermal Energy Storage System (TESS) opportunities in India. Commercial terms and financial commitments have not yet been finalized and will be determined at a later stage. The deal represents an exploratory diversification into energy storage, distinct from its core operations which delivered Rs 12.45 cr revenue in the quarter ended June 2026.
- Entered into a strategic partnership agreement with Storenergy Limited, incorporated in England.
- Purpose is to collaborate on evaluation, development, and pursuit of Thermal Energy Storage Systems (TESS) in India.
- Commercial terms and financial consideration are not disclosed and will be decided at a later stage.
- The transaction does not qualify as a related party transaction.
Gujarat Inject Kerala Ltd has appointed Mr. Radadiya HardikKumar AnilBhai as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective August 10, 2026. The appointee brings 7 years of experience in accounting, taxation, and financial reporting. The Board of Directors approved this appointment in a meeting held on the same day, which lasted 45 minutes. This change also updates the authorized personnel for determining materiality of events under SEBI LODR regulations.
- Appointment of Mr. Radadiya HardikKumar AnilBhai as CFO effective August 10, 2026
- New CFO possesses 7 years of professional experience in the accounting and taxation field
- Board meeting for the appointment concluded within 45 minutes (04:00 P.M. to 04:45 P.M.)
- Appointee holds a Master of Computer Applications (MCA) degree
- Stock has seen a 398.3% price return over the last 12 months despite missing financial data
Gujarat Inject Kerala Ltd has scheduled an Extra Ordinary General Meeting (EGM) for August 12, 2026, to seek shareholder approval for a major strategic pivot. The company intends to change its name to 'REGENOVA RENEWTECH LIMITED' to reflect a new focus on solar-related activities, moving away from its pharmaceutical roots. This follows a previous name change proposal from April 2025 which the board now seeks to rescind as it did not adequately reflect the new business direction. The stock has seen a significant 461.9% price return over the last 12 months, likely anticipating this diversification.
- EGM scheduled for August 12, 2026, to approve a pivot into solar-related activities
- Proposed name change to 'REGENOVA RENEWTECH LIMITED' from 'Gujarat Inject Kerala Limited'
- Rescinding a previous special resolution passed on April 3, 2025, for a different name change
- Cut-off date for e-voting eligibility set for August 5, 2026
- Remote e-voting period to run from August 8, 2026, to August 11, 2026
Gujarat Inject Kerala reported a massive 414.4% YoY revenue growth to 12.45 Cr in Q1 FY27, driven by its strategic pivot into the solar energy sector. Net profit surged to 1.25 Cr, which represents 69% of the total profit earned in the entire previous fiscal year (FY26). The company is formalizing this transition by proposing a name change to Regenova Renewtech Limited and has appointed Mr. Murli Shivshankaran Nair as Managing Director. While revenue declined sequentially from a peak Q4 FY26 of 30.70 Cr, the bottom-line remains significantly stronger than historical levels.
- Q1 FY27 Revenue grew 414.4% YoY to 12.45 Crore from 2.42 Crore.
- Net Profit (PAT) reached 1.25 Crore, a massive jump from 0.07 Crore in Q1 FY26.
- Q1 FY27 PAT accounts for 69% of the total FY26 full-year PAT of 1.81 Crore.
- Company operates its own 5MW solar project in Jakasana, Mehsana (Gujarat).
- Proposed name change to REGENOVA RENEWTECH LIMITED to reflect the shift from Pharma to Clean Tech.
Gujarat Inject Kerala Ltd has approved its unaudited financial results for the quarter ended June 30, 2026. The company reported a Basic EPS of Rs 1.24, representing a 44% increase from Rs 0.86 in the preceding quarter and a 10.7% increase from Rs 1.12 in the same quarter last year. Notably, the quarterly EPS of Rs 1.24 significantly exceeds the full-year FY26 EPS of Rs 0.05, suggesting a sharp recovery or high volatility in earnings. The statutory auditors, M/s. S Mandawat & Co., issued a limited review report with no material qualifications.
- Basic and Diluted EPS for Q1 FY27 stood at Rs 1.24.
- EPS grew 44.18% sequentially from Rs 0.86 in the March 2026 quarter.
- EPS grew 10.71% year-on-year from Rs 1.12 in the June 2025 quarter.
- The reported quarterly EPS of Rs 1.24 is substantially higher than the full-year FY26 EPS of Rs 0.05.
- Board meeting was efficient, concluding in 45 minutes (09:00 AM to 09:45 AM).
Gujarat Inject Kerala Ltd reported its unaudited financial results for Q1 FY27 (ended June 30, 2026). The company posted a Basic EPS of 1.24, showing growth from 1.12 in the same quarter last year and 0.86 in the preceding quarter. This performance is a significant improvement over the full-year FY26 EPS of 0.05. Given the stock's 461.9% return over the past 12 months, these results provide critical fundamental data to assess the sustainability of the recent price rally.
- Basic EPS for the quarter ended June 30, 2026, reported at 1.24
- Quarter-on-Quarter EPS growth of approximately 44% from 0.86 in Q4 FY26
- Year-on-Year EPS growth of 10.7% from 1.12 in Q1 FY26
- Full-year EPS for the previous fiscal year was significantly lower at 0.05
- Board meeting for result approval concluded in 45 minutes (09:00 to 09:45)
The Board of Gujarat Inject Kerala Ltd approved a name change to 'REGENOVA RENEWTECH LIMITED' on July 14, 2026, signaling a major strategic pivot. The company plans to shift its business focus from pharmaceuticals to solar-related activities. This proposal is subject to shareholder approval at the upcoming general meeting. While the stock has delivered a 461.9% return over the past 12 months, the financial details and execution plan for the solar venture remain undisclosed.
- Board approved name change to REGENOVA RENEWTECH LIMITED on July 14, 2026
- Company is pivoting from Pharmaceuticals to focus on solar-related activities
- Stock has seen a significant 12-month price return of 461.9%
- Board meeting concluded within 30 minutes (03:15 PM to 03:45 PM)
- The 6-month price return stands at 222.4% as of the announcement date
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
